Literature DB >> 15379780

Oxidative damage of biomolecules in mouse liver induced by morphine and protected by antioxidants.

Yun-Tao Zhang1, Qiu-Sheng Zheng, Jing Pan, Rong-Liang Zheng.   

Abstract

This study investigates the oxidative damage of biomolecules in livers of mice treated with morphine intraperitoneally. The oxidative damage of DNA as measured by single cell electrophoresis and high-performance liquid chromatography equipped with electrochemical and UV detection, the protein carbonyl content was measured by 2,4-dinitrophenylhydrazine method, and the malondialdehyde content was measured by the HPLC method. The activities of antioxidative enzymes, superoxide dismutase, catalase and glutathione peroxidase, and the activity of alanine aminotransferase were assayed by spectrophotometer method. Glutathione and oxidized glutathione were detected by fluorescence spectrophotometer method. All the indexes of oxidative damage, such as 8-OHdG, protein carbonyl group and malondialdehyde content, and the activity of alanine aminotransferase (n=27) increased significantly compared to those of control (n=27) (P<0.01) in livers of morphine-administered alone mice, while the indexes related with the in vivo antioxidative capacity, such as the ratio of glutathione and oxidized glutathione, activities of superoxide dismutase, catalase and glutathione peroxidase significantly decreased (P<0.01). When mice were treated with morphine combined with exogenous antioxidants, glutathione and ascorbic acid, all the indexes of oxidative damage and the activity of alanine aminotransferase showed no changes as compared to those of control (P>0.05), i.e., both glutathione and ascorbic acid completely abolished the damage of morphine on the hepatocyte. These results implied that morphine caused a seriously oxidative stress in mice livers and hence caused hepatotoxicity, while exogenous antioxidants were able to prevent the oxidative damage of biomolecules and hepatotoxicity caused by morphine. Thus, blocking oxidative damage may be a useful strategy for the development of a new therapy for opiate abuse. Copyright 2004 Basic & Clinical Pharmacology & Toxicology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15379780     DOI: 10.1111/j.1742-7843.2004.950202.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  46 in total

1.  Novel protective mechanisms for S-adenosyl-L-methionine against acetaminophen hepatotoxicity: improvement of key antioxidant enzymatic function.

Authors:  James Michael Brown; John G Ball; Michael Scott Wright; Stephanie Van Meter; Monica A Valentovic
Journal:  Toxicol Lett       Date:  2012-06-05       Impact factor: 4.372

Review 2.  Vitamin C, Pain and Opioid Use Disorder.

Authors:  Erica Zelfand
Journal:  Integr Med (Encinitas)       Date:  2020-06

3.  Concurrent Inflammation Augments Antimalarial Drugs-Induced Liver Injury in Rats.

Authors:  Hossein Niknahad; Reza Heidari; Roya Firuzi; Farzaneh Abazari; Maral Ramezani; Negar Azarpira; Massood Hosseinzadeh; Asma Najibi; Arastoo Saeedi
Journal:  Adv Pharm Bull       Date:  2016-12-22

4.  Effect of chronic usage of tramadol on motor cerebral cortex and testicular tissues of adult male albino rats and the effect of its withdrawal: histological, immunohistochemical and biochemical study.

Authors:  Fatma M Ghoneim; Hanaa A Khalaf; Ayman Z Elsamanoudy; Ahmed N Helaly
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

5.  HIV-1 coinfection and morphine coexposure severely dysregulate hepatitis C virus-induced hepatic proinflammatory cytokine release and free radical production: increased pathogenesis coincides with uncoordinated host defenses.

Authors:  Nazira El-Hage; Seth M Dever; Sylvia Fitting; Tasrif Ahmed; Kurt F Hauser
Journal:  J Virol       Date:  2011-09-07       Impact factor: 5.103

6.  Antinociceptive activity of Copaifera officinalis Jacq. L oil and kaurenoic acid in mice.

Authors:  Diéssica Padilha Dalenogare; Paula Ronsani Ferro; Samira Dal Toé De Prá; Flávia Karine Rigo; Caren Tatiane de David Antoniazzi; Amanda Spring de Almeida; Adriani Paganini Damiani; Giulia Strapazzon; Thanielly Thais de Oliveira Sardinha; Nathália Coral Galvani; Aline Augusti Boligon; Vanessa Moraes de Andrade; Evelyne da Silva Brum; Sara Marchesan Oliveira; Gabriela Trevisan
Journal:  Inflammopharmacology       Date:  2019-05-16       Impact factor: 4.473

7.  Spinal morphine administration reduces the fatty acid contents in spinal cord and brain by increasing oxidative stress.

Authors:  Ismail Ozmen; Mustafa Naziroğlu; H Ahmet Alici; Fikrettin Sahin; Mustafa Cengiz; Ibrahim Eren
Journal:  Neurochem Res       Date:  2006-12-07       Impact factor: 3.996

8.  Opioid use affects antioxidant activity and purine metabolism: preliminary results.

Authors:  Paolo Mannelli; Ashwin Patkar; Steve Rozen; Wayne Matson; Ranga Krishnan; Rima Kaddurah-Daouk
Journal:  Hum Psychopharmacol       Date:  2009-12       Impact factor: 1.672

9.  Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats.

Authors:  M R Ebrahimkhani; S Kiani; F Oakley; T Kendall; A Shariftabrizi; S M Tavangar; L Moezi; S Payabvash; A Karoon; H Hoseininik; D A Mann; K P Moore; A R Mani; A R Dehpour
Journal:  Gut       Date:  2006-03-16       Impact factor: 23.059

10.  Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice.

Authors:  Mohammad Nasehi; Samaneh Amin Yavari; Mohammad Reza Zarrindast
Journal:  Psychopharmacology (Berl)       Date:  2013-02-13       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.